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 On March 27, 2002 the Department of Health and Human Services (HHS)
published its proposed changes to the medical privacy regulations issued by the Clinton
Administration under the Health Insurance Portability and Accountability Act of 1996
(“HIPAA”).  HHS is accepting comments on the proposed changes until April 26, 2002.
This report provides an overview of the final rule for “Standards for the Privacy of
Individually Identifiable Health Information” ( “privacy rule”) that went into effect on
April 14, 2001, and an overview of the Bush Administration’s proposed changes to the
privacy regulation.  Many of the proposed changes address problems identified by HHS
in its guidance on the privacy rule issued  July 2001.  However, the proposed rule also
contains a number of revisions that were not identified in the July 2001 guidance.  Some
changes are more significant than others.  HIPAA expressly permits the HHS Secretary
to modify any of its required standards, such as the privacy standard, after the first year,
once every 12 months.  There is no target date for the publication of the final rule, but
it must be published by October 13, 2001 to meet the requirement that covered entities
have 180 days to incorporate changes.  The compliance deadline is April 2003. For
detailed discussion of medical privacy issues, see CRS Report RL30620, Health
Information Security and Privacy: HIPAA and Proposed Implementing Regulations.
On December 28, 2000, shortly before the Clinton Administration left office, HHS
published the final rule on health information privacy, as required by the Health Insurance
Portability and Accountability Act of 1996 (HIPAA).1  HIPAA was created to improve the
portability and continuity of health insurance coverage, to combat waste, fraud and abuse
in health care, to promote the use of medical savings accounts, to improve access to long
term care, and to simplify the administration of health insurance.2  Sections 261 through
264 of HIPAA are known as the administrative simplification provisions.  The general
administrative simplification rule requires health care payers and providers who transmit
transactions electronically to use standardized data elements to conduct financial and
administrative transactions.  Section 262 directs HHS to issue standards to facilitate the
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electronic exchange of information, and to develop standards to protect the security of
such information.  Section 264 of HIPAA requires HHS to submit to the Congress detailed
recommendations on standards with respect to the privacy rights that an individual who
is the subject of individually identifiable health information should have, the procedures
that should be established for the exercise of such rights, and the uses and disclosures of
such information that should be authorized or required.  HIPAA establishes timetables for
the adoption, addition, and modification of the administrative simplification standards.
HIPAA provides that, subject to limited exceptions, the Secretary shall review the
standards, and  adopt appropriate additions or modifications to the standards, not more
frequently than once every 12 months.3  Additions or modifications are to be completed
in a manner that minimizes the disruption and cost of compliance. The Secretary is not
permitted to modify any standard, except for the code sets standard, during the 12 month
period beginning on the date that the standard is initially adopted “unless the Secretary
determines that the modification is necessary in order to permit compliance with the
standard.” (emphasis added).4  Modifications to any of the standards may be made after
the first year, but not more than once every 12 months.
The Secretary made her preliminary privacy recommendations to Congress on
September 11, 1997.5  In the 106th Congress several proposals to protect health
information were considered, but Congress did not pass legislation.6  None of the bills
were reported out of committee, with disagreements over the patient’s right to sue,
parental notification of minor’s access to health care, and preemption precluding
agreement.  In the absence of the enactment of federal legislation, HIPAA required HHS
to issue final privacy regulations.  The final privacy regulation was published on
December 28, 2000 after HHS received over 52,000 comments on its initial proposal.
The final regulation issued in December 2000 was intended to create a new federal
floor of privacy protections that leaves in place more protective state rules or practices.
It describes a set of basic consumer protections and a series of regulatory permissions for
use and disclosure of protected health information.  HHS estimates that the 10-year costs
of implementing the privacy regulation will be $17.6 billion, offset by $29 billion in savings
over 10 years from the transaction and code set rule required by HIPAA.  Net savings for
the two rules are forecast to be $12.3 billion.  The final regulation applies to a specified
set of entities, referred to as covered entities:  health plans, health care clearinghouses
(entities that process or facilitate the processing of nonstandard data elements of health
information into standard data elements), and health care providers who transmit any
health information in electronic form in connection with an administrative simplification
transaction.  Entities covered by the health information privacy rule have until April 2003
to comply, with the exception of small health plans (those with annual receipts  of $5
million or less) who have until 2004 to comply.
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The regulations cover all protected health information in any form, whether oral,
written or electronic.  The use of protected health information for treatment, payment, or
health care operations7 requires the prior written consent of a patient, except in certain
circumstances.  Uses and disclosures of protected health information for purposes other
than treatment, payment, and health care operations require a prior detailed and explicit
written authorization from the individual.  Entities covered by the regulation must enter
into contracts with “business associates” requiring them to protect individual health
information.  Covered entities must take action if they know of practices by their business
associates that violate the contractual agreement.  Most disclosures of protected health
information other than for treatment must use only the “minimum necessary”
information.  Covered entities must adhere to specific procedures in using information for
fundraising or marketing. The regulation also establishes special requirements for use of
protected health information that apply to both federal and privately funded research.
Individuals are given a right of access to their health information, a right to receive notice
of the covered entity’s privacy policies, a right to request amendments of their information,
a right to an accounting of the disclosures made, and a right to file complaints regarding
use or disclosure of their information.  Individuals may request that restrictions be placed
on the disclosure of their health information.  Psychotherapy notes may not be used by, or
disclosed to others without explicit authorization.  Exceptions to the consent and
authorization requirements are provided for certain public priority uses of information,
such as health system oversight, public health activities, certain research activities, law
enforcement, judicial and administrative proceedings, emergency treatment, and imminent
threats to the health or safety of any person.  State law, except for certain specified laws
(concerning public health surveillance) and state laws that are more stringent, is preempted
by the federal rule.
The Secretary, covered entities, and others are required to ascertain compliance with,
and enforcement of the privacy regulation.8  The Secretary is to seek the cooperation of
covered entities in obtaining compliance with the regulation, and is authorized to provide
technical assistance to covered entities to help them comply voluntarily.  The regulation
permits any person to file a complaint with the HHS Office for Civil Rights if the person
believes a covered entity is not complying with the rule.  The regulation provides that the
Secretary may investigate such complaints.  The regulation also authorizes the Secretary
to conduct compliance reviews.  Covered entities are required to provide records and
compliance reports, to cooperate with complaint investigations and compliance reviews,
and to permit access to information.  In cases where a compliance review indicates a
failure to comply, the Secretary is directed to resolve the matter by informal means
whenever possible.  If the matter cannot be resolved informally, the Secretary may issue
written findings documenting the non-compliance.  The non-compliance findings may be
used as a basis for initiating action (civil monetary penalties) or initiating a criminal referral
(penalties for disclosing individually identifiable health information).  Violators will be
subject to civil monetary penalties ($100 per violation up to $25,000 per year), and
criminal penalties (up to $250,000 and imprisonment up to 10 years) against covered
entities that knowingly and improperly disclose identifiable health information.  The
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regulation does not authorize patients to sue to enforce the privacy standards.  However,
a patient may bring a claim in a state where such actions are permitted.
The final privacy rule was criticized for its complexity, and for the imposition of
substantial administrative and financial burdens on health care industry participants.9  At
the same time, the regulation was applauded by privacy advocates, consumer groups, and
some health care industry participants.10  The General Accounting Office (“GAO”) testified
that “considerable uncertainty remains regarding the actions needed to comply with the
new privacy regulations.”11  Concern among the stakeholder groups centered on conditions
for consent, authorization, and disclosures; rules pertaining to the business associates of
covered entities; limited preemption of state laws; the costs of implementation; and HHS’
capacity to provide technical assistance.  Some members of Congress were concerned
about particular aspects of the privacy rule.  House Ways and Means Committee Chairman
William M. Thomas and Health Subcommittee Chairwoman Nancy L. Johnson
recommended that the provision requiring providers to obtain consent to use and disclose
patient health care information for treatment, payment and health care operations be
eliminated, along with the business associate provision to avoid potential contract liability.
Representative Edward Markey and several other members asked President Bush not to
modify several of the regulation’s provisions.  Senate Health, Education, Labor and
Pensions Chairman Edward M. Kennedy and Senate Judiciary Committee Chairman
Patrick J. Leahy were included in this group.  They  recommended that the consent
provision be maintained, and also expressed support for the provision requiring covered
entities to enter into contracts with business associates.  Support was also expressed for
the provision that permits health care providers not to disclose protected health
information to the parents of minor children when state laws,  typically related to
substance abuse, mental health treatment, and reproductive care, permit minors to access
health care without parental consent.
When the final rule was published it had an effective date of  February 26, 2001.
However, HHS subsequently established a later effective date of April 14, 2001.12  On
February 8, 2001, HHS announced that it would accept further comments on the rule up
until March 30, 2001.13  In this notice, HHS stated that the scope and cost of the rule,
coupled with the substantial nature of some concerns raised in the initial comment period,
led it to conclude that an additional comment period was warranted.  HHS Secretary
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Thompson indicated that the Department would “review the comments it receives to
determine whether changes in the final rule are needed.”14  On April 12, 2001, Secretary
Thompson announced that HHS would immediately begin the process of implementing the
patient privacy rule, and of issuing guidelines on how the rule should be implemented in
order “to clarify some of the confusion regarding the impact the rule might have on health
care delivery and access” and also “consider any necessary modifications that will ensure
the quality of care does not suffer inadvertently from this rule.”15   The Secretary
highlighted several areas targeted for clarification or modification:  “that doctors and
hospitals will have access to necessary medical information about a patient they are
treating and they will be able to consult with other physicians and specialists regarding a
patient's care; patient care will be delivered in a timely and efficient manner and not unduly
hampered by the confusing requirements surrounding consent forms; and parents will have
access to information about the health and well-being of their children, including
information about mental health, substance abuse or abortion.”16  The areas of concern
focus on impediments to information sharing, involve consent and authorization
procedures, or relate to parental access to minors’ health information.  On July 6, 2001
HHS issued guidance materials to explain and clarify key provisions of the rule.17
On March 27, 2002, HHS Secretary Tommy G. Thompson published proposed
changes to HHS' health privacy regulations.18  There are several proposed changes to the
privacy rule, with some changes more significant than others.  A significant change in the
proposed rule would eliminate the requirement for providers to obtain, prior to using or
disclosing protected health information, an individual’s written consent for treatment,
payment or health care operations.  Under the proposed rule, covered entities would be
permitted to obtain consent, but would not be required to.  The proposed rule adds a new
requirement that health care providers with a direct treatment relationship must make a
good faith effort to obtain an individual’s written acknowledgment of receipt of the
provider’s notice of privacy practices.  Other covered entities, such as health plans,  would
not be required to obtain the acknowledgment.
Another proposed change relates to disclosures to another entity for payment and
operations.  The current rule prevents a provider from disclosing protected health
information to another entity for other than treatment purposes.  Under the proposed rule,
a covered entity would be permitted to disclose protected health information to other
covered entities, and to noncoverd health care providers, to enable the recipient to make
or obtain payment.  Protected health information, under the proposal, may also be
disclosed to another covered entity for specified operational purposes of the recipient, as
long as both entities have a relationship with the individual.  The proposal clarifies that
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health information for health care operations.
Another focus of the proposed rule is the minimum necessary requirement which
limits the use and disclosure of protected health information for payment or health care
operations to the minimum necessary to accomplish the intended purpose.  In HHS’
guidance to the privacy rule, it states that the minimum necessary requirement was a
reasonableness standard, and that covered entities have flexibility to make their own
assessments of what information is reasonably necessary for particular purposes.  This
statement is repeated in the commentary to the proposed rule, but no changes are
recommended to the final rule in this area.    With respect to oral communications, the
privacy rule protected the disclosure of health information through oral communication.
The proposed rule retains the oral communications requirement, but would explicitly
permit incidental disclosures resulting from activities such as discussions at nursing
stations, the use of sign-in sheets, calling out names in waiting rooms, etc.
Another area of concern in the privacy rule was the provision that permits a covered
entity to disclose protected health information to a business associate who performs a
function on behalf of the covered entity so long as the covered entity enters into a contract
with the business associate specifying safeguards.  The proposed rule would allow covered
entities to continue to operate under existing contracts with business associates for up to
one year beyond the April 14, 2003 compliance date.  Covered entities would still be
required to comply with the patient rights obligations commencing on April 14, 2003.  An
appendix offers model business associate contract provisions.  Although patient
authorizations would still be required to use and disclose information for purposes
outside of treatment, payment, and health care operations, the proposed rule would
standardize the core requirements in the authorization forms, and allow health care groups
to use a single type of authorization to get a patient’s permission to use information for
a specific purpose or disclosure.  The final privacy rule generally does not permit covered
entities to use or disclose protected health information for marketing products or services
that are not health-related, without the express authorization of the individual.  The
proposed rule would require covered entities to obtain an authorization from the individual
before making any marketing communications.  The proposed rule also clarifies the
definition of “marketing.”
The privacy rule generally gives control of health information about a minor to the
parent, guardian, or person acting in loco parentis.  This is not the case where state law
or a court allows the minor, or someone other than the parent to consent to treatment.
The proposed rule would continue to defer to state law, but clarifies that HIPAA does not
overturn state laws that give providers discretion to disclose health information to parents,
or that prohibit disclosure of health information to a parent.  With respect to the use and
disclosure of health information for research, the privacy rule provides that protected
health information may not be used or disclosed for research without either a written
authorization or a waiver of authorization approved by an Institutional Review Board or
a Privacy Board.  In the proposed rule, HHS significantly simplified the administrative
burdens for obtaining authorizations and assessing requests for waivers of authorization.
